Research location
Saint-Brieuc
France
Advertisement
Research activity in Saint-Brieuc
FranceCureCurrent currently publishes aggregate city-level research activity for this location: 113 trials and 117 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Saint-Brieuc
113 linked trials · page 1 of 3A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFNCT07761117 · 2026-08-24 · 1 site observation
RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseNCT07064473 · 2025-07-22 · 1 site observation
RECRUITING
UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ AllianceNCT06726720 · 2024-12-16 · 1 site observation
RECRUITING
Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLCNCT05122806 · 2021-09-22 · 1 site observation
RECRUITING
PRIMUS : Real World Usage for Real World Evidence of CDSS Use in Multiple SclerosisNCT07647952 · 2026-06-30 · 1 site observation
NOT_YET_RECRUITING
Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the ThoraxNCT05617963 · 2023-03-24 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40%NCT04986202 · 2021-06-30 · 1 site observation
COMPLETED
Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple MyelomaNCT04805203 · 2020-12-16 · 1 site observation
TERMINATED
Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19NCT04397588 · 2020-04-21 · 1 site observation
COMPLETED
Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)NCT03888066 · 2019-04-24 · 1 site observation
COMPLETED
Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC PatientsNCT03351361 · 2018-02-19 · 1 site observation
COMPLETED
ANRS CO24 OncoVIHAC (Onco VIH Anti Checkpoint)NCT03354936 · 2018-01-17 · 3 site observations
UNKNOWN
Immunotherapy by Nivolumab for HIV+ PatientsNCT03304093 · 2017-10-19 · 1 site observation
COMPLETED
Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected PatientsNCT03256422 · 2017-09-07 · 1 site observation
COMPLETED
A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLCNCT03215706 · 2017-08-24 · 1 site observation
COMPLETED
Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a DocetaxelNCT02961257 · 2017-05-05 · 1 site observation
COMPLETED
Real Life Second-Line Nivolumab in Advanced Non-Small Cell Lung CancerNCT04858204 · 2017-04-14 · 1 site observation
COMPLETED
PAlbociclib and Circulating Tumor DNA for ESR1 Mutation DetectionNCT03079011 · 2017-03-22 · 1 site observation
COMPLETED
Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU ProgramNCT02933346 · 2016-09-01 · 1 site observation
COMPLETED
Evaluation of Toujeo Insulin in Type 2 Diabetes Patients Inadequately Control With Their Basal Insulin TreatmentNCT02967237 · 2016-01-04 · 1 site observation
COMPLETED
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLASNCT02531516 · 2015-11-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR InhibitorNCT02444390 · 2015-05-19 · 1 site observation
COMPLETED
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the BrainNCT02308020 · 2015-04-20 · 1 site observation
COMPLETED
Geriatric Determinants of General Repercussion of Radiotherapy for Patient Over 75 Years With Prostate CancerNCT02876237 · 2015-02-01 · 1 site observation
COMPLETED
An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast CancerNCT02286362 · 2015-01-14 · 1 site observation
COMPLETED
Retroprospective Real Life Observatory of EribulinNCT02393287 · 2014-11-01 · 1 site observation
COMPLETED
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung CancerNCT02152631 · 2014-10-03 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain Hormonal ReceptorsNCT02162719 · 2014-08-19 · 1 site observation
COMPLETED
A Multicenter Randomized Phase III Study Comparing Second-line Treatment With Chemotherapy Associated or Not to Erlotinib in NSCLC Patients With Secondary Resistance to TKI-EGFRNCT02178397 · 2014-06-01 · 1 site observation
TERMINATED
Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) PatientsNCT02064868 · 2014-01-31 · 1 site observation
TERMINATED
Retrospective Study in Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR)NCT02293733 · 2014-01-01 · 1 site observation
COMPLETED
A Phase III Study for Patients With Metastatic Hormone-naïve Prostate CancerNCT01957436 · 2013-11-13 · 1 site observation
ACTIVE_NOT_RECRUITING
First Line Metastatic Breast Cancer Treatment (ESMERALDA)NCT01941407 · 2013-11-01 · 2 site observations
COMPLETED
A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"NCT01903993 · 2013-08-06 · 1 site observation
COMPLETED
Determine the Frequency of a HTPPE in 5 Years (± on 1 Year) After a First Episode of Idiopathic Pulmonary Embolism.NCT01894204 · 2013-06-27 · 1 site observation
TERMINATED
French National Observatory of the Patients With Non-small Cell Lung (NSCLC) and Molecular TestingsNCT01700582 · 2012-04-01 · 1 site observation
COMPLETED
An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical PracticeNCT01474291 · 2012-01-01 · 1 site observation
COMPLETED
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate CancerNCT01322490 · 2011-11-28 · 1 site observation
COMPLETED
French Biological Observatory on Lung Cancer in Never SmokersNCT01465854 · 2011-11-01 · 1 site observation
COMPLETED
An Observational Study of Avastin (Bevacizumab) in Patients With HER2-metastatic or Locally Advanced Breast CancerNCT01461044 · 2011-09-01 · 1 site observation
COMPLETED
A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based ChemotherapyNCT01328951 · 2011-09-01 · 1 site observation
COMPLETED
Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.NCT02866955 · 2011-06-15 · 1 site observation
COMPLETED
Chemotherapy for Lung Cancer in HIV-positive PatientsNCT01296113 · 2011-05-01 · 1 site observation
COMPLETED
Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukaemia in Long Term After Stopping ImatinibNCT01343173 · 2011-04-06 · 1 site observation
COMPLETED
Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate CancerNCT01308580 · 2011-04-01 · 1 site observation
COMPLETED
Pregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014NCT01503034 · 2010-12-14 · 1 site observation
COMPLETED
Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate CancerNCT01188187 · 2010-11-01 · 1 site observation
COMPLETED
Observational Study on the Management of Patients With Non Small Cell Lung Cancer AdenocarcinomaNCT01167972 · 2010-09-01 · 1 site observation
COMPLETED
An Observational Study of Tarceva (Erlotinib) in Patients With Non-Small Cell Lung CancerNCT01488331 · 2010-06-01 · 1 site observation
COMPLETED
Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast CancerNCT01069796 · 2010-04-01 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.